These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 34532281)
21. Identification of the Expression and Clinical Significance of E2F Family in Clear Cell Renal Cell Carcinoma. Chen R; Zhang Z; Hu B; Jiang M; Zheng P; Deng W; Fu B; Sun T Int J Gen Med; 2022; 15():1193-1212. PubMed ID: 35153510 [TBL] [Abstract][Full Text] [Related]
22. The ancient function of RB-E2F pathway: insights from its evolutionary history. Cao L; Peng B; Yao L; Zhang X; Sun K; Yang X; Yu L Biol Direct; 2010 Sep; 5():55. PubMed ID: 20849664 [TBL] [Abstract][Full Text] [Related]
23. Promising roles of mammalian E2Fs in hepatocellular carcinoma. Zhan L; Huang C; Meng XM; Song Y; Wu XQ; Miu CG; Zhan XS; Li J Cell Signal; 2014 May; 26(5):1075-81. PubMed ID: 24440307 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma. Sun CC; Zhou Q; Hu W; Li SJ; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; Tang QZ; Li DJ Aging (Albany NY); 2018 May; 10(5):973-987. PubMed ID: 29754146 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma. Wang Q; Liu J; Cheang I; Li J; Chen T; Li Y; Yu B Int J Gen Med; 2022; 15():5973-5984. PubMed ID: 35811776 [TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic significance of thrombospondin gene family in gastric cancer. Deng LY; Zeng XF; Tang D; Deng W; Liu HF; Xie YK J Gastrointest Oncol; 2021 Apr; 12(2):355-364. PubMed ID: 34012631 [TBL] [Abstract][Full Text] [Related]
27. Bioinformatics Identification of the Expression and Clinical Significance of E2F Family in Endometrial Cancer. Zhang Y; Wang Z; Ma J; Huo J; Li Y; Wang Y; Chen H; Shan L; Ma X Front Genet; 2020; 11():557188. PubMed ID: 33329696 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of the functional and prognostic value of E2F transcription factors in human prostate cancer through data mining and experimental validation. Wang D; Tang W; Zhang P; Liu Z; Lyu F; Xiao Y; Ni D; Zhang P Transl Cancer Res; 2021 Dec; 10(12):5095-5109. PubMed ID: 35116361 [TBL] [Abstract][Full Text] [Related]
29. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer. Liao P; Han S; Qu H Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564 [TBL] [Abstract][Full Text] [Related]
30. Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis. Liang B; Zhao J; Wang X Genes Cancer; 2017 May; 8(5-6):600-607. PubMed ID: 28740578 [TBL] [Abstract][Full Text] [Related]
31. Systematic study on expression and prognosis of E2Fs in human colorectal cancer. Ma Y; Wang S; Bao J; Wang C Int J Clin Oncol; 2022 Feb; 27(2):362-372. PubMed ID: 34661779 [TBL] [Abstract][Full Text] [Related]
32. Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines. Baiz D; Dapas B; Farra R; Scaggiante B; Pozzato G; Zanconati F; Fiotti N; Consoloni L; Chiaretti S; Grassi G World J Gastroenterol; 2014 Jan; 20(3):795-803. PubMed ID: 24574752 [TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. Maiti B; Li J; de Bruin A; Gordon F; Timmers C; Opavsky R; Patil K; Tuttle J; Cleghorn W; Leone G J Biol Chem; 2005 May; 280(18):18211-20. PubMed ID: 15722552 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer. Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799 [TBL] [Abstract][Full Text] [Related]
35. Transcription factor compensation during mammary gland development in E2F knockout mice. To B; Andrechek ER PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434 [TBL] [Abstract][Full Text] [Related]
36. E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer. Gan Z; Abudurexiti A; Hu X; Chen W; Zhang N; Sang W Medicine (Baltimore); 2024 Jan; 103(2):e35722. PubMed ID: 38215110 [TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients. Reimer D; Sadr S; Wiedemair A; Stadlmann S; Concin N; Hofstetter G; Müller-Holzner E; Marth C; Zeimet AG Clin Cancer Res; 2007 Jan; 13(1):144-51. PubMed ID: 17200349 [TBL] [Abstract][Full Text] [Related]
38. Transcriptional E2F1/2/3/6 as potential prognostic biomarkers in cutaneous melanoma. Li J; Shu XL; Shao Q; Luo Q; Diao QC; Zhang X; Sui JD; Guo J; Tao D; Zhou X; Wang Y; Wang C Am J Transl Res; 2021; 13(1):420-433. PubMed ID: 33527034 [TBL] [Abstract][Full Text] [Related]
39. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis. Gao Z; Shi R; Yuan K; Wang Y Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285 [TBL] [Abstract][Full Text] [Related]
40. Analysis the prognostic values of solute carrier (SLC) family 39 genes in gastric cancer. Ding B; Lou W; Xu L; Li R; Fan W Am J Transl Res; 2019; 11(1):486-498. PubMed ID: 30788004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]